A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury

Overview of attention for article published in Trials, May 2022

Altmetric Badge

Mentioned by

twitter: 7 X users

Readers on

mendeley: 30 Mendeley

Summary X

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 22,098 followers.

@jamesfomahony @statsepi https://t.co/yyCbHeqNhP https://t.co/fh0Y9Trczo

25 Oct 2022

Reply Repost Favourite

RT @LSHTM_GHECO: Tranexamic acid can be used to treat mild traumatic brain injury (TBI), a leading cause of death & #disability in older ad…

06 May 2022

Reply Repost Favourite

Tranexamic acid can be used to treat mild traumatic brain injury (TBI), a leading cause of death & #disability in older adults 🧠 Early economic modelling shows there is a high value of future research on the treatment. ➡️ https://t.co/S1MmWhMU7M #TX

06 May 2022

Reply Repost Favourite

RT @CTU_LSHTM: Mild #TBI in older adults is a huge problem in the UK. Finding out if #TXA improves outcomes is well worth the cost accordin…

06 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.